| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $0 (Miss by $-0.3273) |
| EPS GAAP Actual | $0 (Miss by $-0.3273) |
| Revenue Actual | $5.975B |
| Revenue Surprise | Beat by $5975M |
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.35496 |
| EPS GAAP Estimate | $0.35496 |
| Revenue Estimate | $2.059181439B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 |
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.63 | 1.63 | 5.975B | 8.89% | 5975M |
| FQ2 2025 (Jun 2025) | -0.013 | -0.013 | 5.429B | 5.36% | 5429M |
| FQ1 2025 (Mar 2025) | 0.23 | 0.23 | 5.392B | 3.8% | 5392M |
| FQ4 2024 (Dec 2024) | 0.39 | 0.39 | 5.444B | 8.71% | 5444M |
| FQ3 2024 (Sep 2024) | -0.16 | -0.16 | 5.27B | 100% | 5270M |
| FQ2 2024 (Jun 2024) | -0.0823 | -0.0823 | 5.138B | 17.17% | 5138M |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 5.187B | 18.68% | 5187M |
| FQ4 2023 (Dec 2023) | -0.2 | -0.2 | 4.97B | 100% | 4970M |
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
0.35496
Consensus Revenue Estimates
2.059181439B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 0.3157 | -- | 0.3157 | 0.3157 | 1 |
| FQ4 2027 (Nov 2027) | 0.2815 | -- | 0.2815 | 0.2815 | 1 |
| FQ3 2027 (Aug 2027) | 0.2517 | -- | 0.2517 | 0.2517 | 1 |
| FQ2 2027 (May 2027) | 0.2727 | -- | 0.2727 | 0.2727 | 1 |
| FQ1 2027 (Feb 2027) | 0.2585 | -- | 0.2585 | 0.2585 | 1 |
| FQ4 2026 (Nov 2026) | 0.063154 | -2480.99 | 0.063154 | 0.063154 | 1 |
| FQ3 2026 (Aug 2026) | 0.30906 | -- | 0.30906 | 0.30906 | 1 |
| FQ2 2026 (May 2026) | 0.28743 | 104.52 | 0.28743 | 0.28743 | 1 |
| FQ1 2026 (Mar 2026) | 0.35496 | 35.2 | 0.35496 | 0.35496 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Feb 2028) | 6.81B | -- | 6.81B | 6.81B | 1 |
| FQ4 2027 (Nov 2027) | 6.72B | -- | 6.72B | 6.72B | 1 |
| FQ3 2027 (Aug 2027) | 6.62B | -- | 6.62B | 6.62B | 1 |
| FQ2 2027 (May 2027) | 6.52B | -- | 6.52B | 6.52B | 1 |
| FQ1 2027 (Feb 2027) | 6.43B | -- | 6.43B | 6.43B | 1 |
| FQ4 2026 (Nov 2026) | 2.26B | -164.95 | 2.26B | 2.26B | 1 |
| FQ3 2026 (Aug 2026) | 2.23B | -- | 2.23B | 2.23B | 1 |
| FQ2 2026 (May 2026) | 2.21B | -146.21 | 2.21B | 2.21B | 1 |
| FQ1 2026 (Mar 2026) | 2.06B | -161.85 | 2.06B | 2.06B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.63 | 1.63 | 100% | |
| FQ2 2025 (Jun 2025) | -0.013 | -0.013 | 100% | |
| FQ1 2025 (Mar 2025) | 0.23 | 0.23 | 100% | |
| FQ4 2024 (Dec 2024) | 0.39 | 0.39 | 100% | |
| FQ3 2024 (Sep 2024) | -0.16 | -0.16 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0823 | -0.0823 | 100% | |
| FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% | |
| FQ4 2023 (Dec 2023) | -0.2 | -0.2 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $5.98B | $5975M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $5.43B | $5429M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $5.39B | $5392M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.44B | $5444M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $5.27B | $5270M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.14B | $5138M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.19B | $5187M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.97B | $4970M | 100% |